Invasive meningococcal disease cases up in 2025

The Shifting Landscape of Meningococcal Disease: What Recent Trends Reveal

Tracking the evolution of invasive meningococcal disease (IMO) is more than a clinical exercise. it is a vital early-warning system for public health. Recent surveillance data from the Czech Republic indicates a subtle but significant shift in how Neisseria meningitidis is behaving, highlighting novel vulnerabilities in the population and emerging challenges in treatment.

In 2025, the number of IMO cases rose to 23, representing an incidence of 0.21/100,000 inhabitants. This is a notable increase from 2024, which saw 15 cases (0.14/100,000 inhabitants). While the raw numbers remain low, the underlying patterns—specifically regarding age groups and serogroups—suggest a changing epidemiological tide.

The Infant Vulnerability Gap

One of the most concerning trends is the spike in morbidity among the youngest patients. In the 0-11 month age group, the incidence climbed significantly to 4.72/100,000 in 2025, compared to just 1.09/100,000 the previous year.

This trend is particularly pronounced in diseases caused by serogroup B, where the incidence in infants rose to 3.54/100,000 from 1.09/100,000. The human cost of this shift is evident: of the three deaths recorded in 2025—resulting in a total mortality rate of 13.04%—two occurred in the 0-11 month category.

Interestingly, this increase in the youngest cohort contrasts with a decrease in the 1-4 year age group, where incidence dropped to 0.23/100,000 from 0.67/100,000. This divergence suggests that the drivers of infection may be shifting toward early neonatal and infant exposure.

The Rise of Serogroup W and the Diversity of Strains

While serogroup B remains the most prevalent—accounting for 15 of the 23 cases in 2025—the emergence of serogroup W is a point of focus for epidemiologists. After showing no proven occurrence in 2023-2024, serogroup W appeared in four cases in 2025, surpassing serogroup C, which was found in three cases.

Advanced genetic mapping, including whole-genome sequencing (WGS) and multilocus sequence typing (MLST), reveals a high level of heterogeneity among the isolates. Out of 16 strains analyzed, 13 belonged to various virulent clonal complexes currently endemic across Europe, such as cc11, cc18, and cc32.

This diversity indicates that the Czech Republic is not facing a single outbreak from one source, but rather a steady influx of various highly virulent strains circulating throughout the European continent.

The Stealthy Threat of Antibiotic Resistance

For most patients, the current arsenal of antibiotics remains effective. Testing on 16 isolates showed susceptibility to penicillin, ampicillin, cefotaxime, ciprofloxacin, chloramphenicol, and rifampicin.

However, a worrying trend is emerging beneath the surface. While only one isolate was fully resistant to penicillin, four other strains showed MIC (Minimum Inhibitory Concentration) values on the very edge of the breakpoint for resistance. This aligns with a global increase in strains possessing mosaic variants of the penA gene, which can gradually reduce the effectiveness of first-line treatments.

If this trend continues, the medical community may see a gradual shift where standard penicillin treatments turn into less reliable, necessitating a move toward more potent or combination therapies.

Precision Diagnostics: Beyond the Culture Dish

The way we detect IMO is also evolving. Traditional culture methods are still the gold standard, proving 65.2% of cases in 2025. However, the role of PCR (Polymerase Chain Reaction) is becoming indispensable.

In 2025, 30.4% of cases were proven by PCR only. This is critical because PCR can detect the pathogen’s DNA even after antibiotics have been administered or when the bacteria are too few to grow in a culture. The integration of WGS allows health officials to track the exact “fingerprint” of a strain, ensuring that sporadic cases aren’t missed and that potential epidemics are caught in their infancy.

For more information on global prevention strategies, you can visit the World Health Organization (WHO) guidelines on meningitis.

Frequently Asked Questions

Which serogroup is currently the most common in the Czech Republic?
Serogroup B remains the most prevalent, accounting for 15 out of 23 cases in 2025.

Is there a specific age group at higher risk?
Recent data shows a significant increase in morbidity among infants aged 0-11 months, where the incidence rose to 4.72/100,000.

Are antibiotics still effective against these strains?
Yes, most strains remain susceptible, though there is a concerning trend of increasing MIC values for penicillin, suggesting a move toward potential resistance.

What is the difference between culture and PCR testing?
Culture grows the actual bacteria from a sample, while PCR detects the genetic material (DNA) of the bacteria, which is often more sensitive and faster.